Kaposiform Hemangioendothelioma with Bone Destruction: A 16-Year Follow-Up Cohort Study of the Clinical Characteristics and Prognosis

jpedsurg.org

Kaposiform hemangioendothelioma (KHE) is a rare, locally aggressive vascular tumor that often occurs in infants and young children. The goal of this study was to analyze the clinical characteristics of KHE patients with bone destruction and provide clinical guidance for diagnosis and treatment.

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Dec 2023 · 1 min read

In brief

This 16-year cohort study examines kaposiform hemangioendothelioma cases complicated by bone destruction, a rare presentation of an already uncommon pediatric vascular tumor. The research provides long-term outcome data and clinical guidance for managing this aggressive variant in infants and children.

KHE is a rare, locally aggressive vascular tumor predominantly affecting infants and young children.
Bone destruction can occur as a complication of KHE, requiring careful imaging evaluation.
16-year follow-up data provides insights into long-term prognosis and disease progression patterns.
Early recognition of bone involvement is critical for guiding treatment decisions in KHE patients.
Clinical characteristics of KHE with bone destruction differ from standard presentations, warranting specialized management.

Written by the GCMD Library team from the article.

Read it at the source ↗